Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
about
Big Data Analytics for Prostate RadiotherapyInitial evaluation of automated treatment planning softwareVolumetric modulated arc therapy: a review of current literature and clinical use in practice.The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome.Unilateral neck therapy in the human papillomavirus ERA: accepted regional spread patterns.Monte Carlo-based 3-dimensional dosimetry of salivary glands in radioiodine treatment of differentiated thyroid cancer estimated using 124I PETRadiotherapy dose-volume effects on salivary gland functionPredicting radiotherapy outcomes using statistical learning techniques.Parotid gland function after radiotherapy: the combined michigan and utrecht experience.Effect of induction chemotherapy on swallow physiology and saliva production in patients with head and neck cancer: a pilot studyProof of principle of ocular sparing in dogs with sinonasal tumors treated with intensity-modulated radiation therapy.Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessmentsImpact of Radiotherapy Dose on Dentition Breakdown in Head and Neck Cancer Patients.Dosimetric impact of target definitions on normal structures in head and neck cancer.Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancerTreatment planning constraints to avoid xerostomia in head-and-neck radiotherapy: an independent test of QUANTEC criteria using a prospectively collected dataset.Parotid gland-recovery after radiotherapy in the head and neck region--36 months follow-up of a prospective clinical study.Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy.Improved normal tissue sparing in head and neck radiotherapy using biological cost function based-IMRTRadiobiological evaluation of intensity modulated radiation therapy treatments of patients with head and neck cancer: A dual-institutional study.Improving IMRT-plan quality with MLC leaf position refinement post plan optimization.Radiotherapy of nasopharyngeal cancer using Rapidarc: dosimetric study of military teaching hospital Mohamed V, MoroccoClinical evaluation of intensity-modulated radiotherapy for head and neck cancers.Ultrasound histogram assessment of parotid gland injury following head-and-neck radiotherapy: a feasibility study.Measuring side effects after radiotherapy for pharynx cancer.Late oral complications following radiotherapy for head and neck cancers.Advances in radiation therapy of head and neck cancer.IMRT for head and neck cancer: reducing xerostomia and dysphagia.Clinical application of intensity-modulated radiotherapy for head and neck cancer.Post-radiation dental index: development and reliabilityThe treatment outcome and radiation-induced toxicity for patients with head and neck carcinoma in the IMRT era: a systematic review with dosimetric and clinical parameters.Superficial parotid lobe-sparing delineation approach: a better method of dose optimization to protect the parotid gland in intensity-modulated radiotherapy for nasopharyngeal carcinoma.Recent advances in image-guided radiotherapy for head and neck carcinoma.Developing an adaptive radiation therapy strategy for nasopharyngeal carcinoma.First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial.A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life.A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact.Organ-sparing radiation therapy for head and neck cancer.Salivary gland sparing in the treatment of head and neck cancer.IMRT and IGRT in head and neck cancer: Have we delivered what we promised?
P2860
Q26744485-6D86C55D-5D24-4D17-AEB1-7CCE38FDA28EQ28275470-D3E72BB1-789A-4A01-81F4-E50C0A6AA1EFQ30461426-F8900AC8-5FD8-4243-9177-54720AE86B48Q33532886-480D065D-937D-4A24-9D13-E542E52A0CBDQ33682653-03A23231-0E53-47B0-935D-17E92078004DQ33682852-E744CD0C-9D15-420A-94F4-F5CE954B9852Q33698809-61E1DCC2-5399-470B-AEF5-09AEF61F9FDDQ33698936-BC8AE83E-133A-4285-8D6E-27ED106B61CFQ33927574-BE37DC5B-042A-49C3-A387-B0142F49DC53Q34071285-6D12F256-5324-4AAB-95D4-574E4AD86895Q34250979-2256FE94-CD0B-4B3B-9B41-B039F5026AC2Q34498711-4ED5E7EE-6B3C-4758-87A3-99593C40FABBQ35165634-669DAE70-13A7-4BFA-88B3-36F8FF27EDB2Q35203854-3E4D5B4E-CEA2-4EBD-9E05-DEA4D69E8632Q35216218-BF6B0A6E-6ABE-4579-BF3E-AD00AADAF15CQ35333231-D7FFEFC3-24FB-4249-A56C-EEDB338ECBF5Q35447918-6D50B418-63B4-4D02-AE68-29644874D759Q35605323-E0E5BEAC-D0B3-4106-A732-35BCB7B15223Q35875678-D508745E-456C-4B90-A6D5-3C552A27BECDQ36124529-5F9B6096-CF4B-4D6A-A134-1324A4E5B06AQ36157062-BE610F24-7FFC-46AC-B558-0A0B5750BEE2Q36292324-D04347C7-0102-44B1-9A42-BA3C51B55AA7Q36343896-810E2216-D082-4D54-9AC8-DBBC79FA9331Q36787624-CA70EDB0-681F-4EBC-9DCE-B245E0C430A0Q36946726-F2979EC9-F84B-4149-8FDE-DE7F77A44AFAQ36950474-C211B894-23B0-40FE-9974-78CABF70E73FQ37134458-2069FB7A-AF0D-432C-9E8A-10A02631D27CQ37187245-AB093F49-502C-4C1B-AE36-E7D7A043B180Q37217016-13ED0511-B6B2-4283-8DA2-5AA13E823ADDQ37259248-A9626DA3-54E0-4B35-9D22-A424B93E2668Q37283393-4B853128-2036-49E7-9D17-0F1700173107Q37364618-50A482D1-B57D-4E98-A299-68C85418EDB4Q37567466-B84250EC-FEF4-42F2-B7C3-EF742FCEACA1Q37632549-8BE38568-D115-4833-80D1-175468D93B9BQ37686456-EE8CFB6E-30C2-4C54-8800-B278295E8D6FQ37711059-4188600D-0881-4BCD-BF43-16C7C4243809Q37718044-4366A251-249B-49D8-9624-A8E4685641ADQ37905536-31D7BF7F-31FE-4D48-8F2A-7434127E520CQ37934975-AD465B6D-36E7-4D53-92BC-F0C337B2ED8AQ38038841-2CAC49E1-1405-4FC8-8CB1-85A9D3198ABB
P2860
Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Dose-volume modeling of saliva ...... cancer receiving radiotherapy.
@en
Dose-volume modeling of saliva ...... cancer receiving radiotherapy.
@nl
type
label
Dose-volume modeling of saliva ...... cancer receiving radiotherapy.
@en
Dose-volume modeling of saliva ...... cancer receiving radiotherapy.
@nl
prefLabel
Dose-volume modeling of saliva ...... cancer receiving radiotherapy.
@en
Dose-volume modeling of saliva ...... cancer receiving radiotherapy.
@nl
P2093
P1476
Dose-volume modeling of saliva ...... cancer receiving radiotherapy.
@en
P2093
Angel I Blanco
Gregg E Franklin
Issam El Naqa
K S Clifford Chao
Konstantin Zakarian
Milos Vicic
P304
P356
10.1016/J.IJROBP.2004.12.076
P407
P50
P577
2005-07-01T00:00:00Z